Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma. Chen D, Le SB, Hutchinson TE, Calinescu AA, et al. J Clin Invest 2022;132.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen D, Le SB, Hutchinson TE, Calinescu AA, et al. Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma. J Clin Invest 2022;132.
PMID: 35199647